Atara Biotherapeutics (ATRA) Capital Expenditures (2014 - 2024)
Atara Biotherapeutics (ATRA) posted Capital Expenditures of $90,000 for Q4 2024, up 104.5% from $44,000 a year earlier.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Capital Expenditures (2014 - 2024) Analysis & Trends
For FY2024, Atara Biotherapeutics' Capital Expenditures came in at $246,000, down 79.9% from FY2023.
- Annual Capital Expenditures has declined for three consecutive years, with a five-year compound annual growth rate of -46.7% (FY2019 to FY2024).
- In prior years, Atara Biotherapeutics' Capital Expenditures was $1.22 million in FY2023 (-70.8%), $4.19 million in FY2022 (-60.4%), $10.58 million in FY2021 (+134.4%) and $4.51 million in FY2020 (-21.3%).
- Quarterly Capital Expenditures has run from a low of $29,000 in Q2 2024 to a high of $3.86 million in Q3 2021 over five years.
- On a year-over-year basis, Capital Expenditures increased in three of the last seven quarters, with an average decline of 10.8%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2021, with growth of 666.6%; the weakest was Q4 2022, with a decline of 98.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 90,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Mar 31, 2024 | 127,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 281,000.00 |
| Jun 30, 2023 | 499,000.00 |
| Mar 31, 2023 | 399,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Sep 30, 2022 | 132,000.00 |
| Jun 30, 2022 | 1.42 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 3.86 Mn |
| Jun 30, 2021 | 2.06 Mn |
| Mar 31, 2021 | 2.20 Mn |
| Dec 31, 2020 | 601,000.00 |
| Sep 30, 2020 | 503,000.00 |
| Jun 30, 2020 | 2.08 Mn |
| Mar 31, 2020 | 1.33 Mn |
| Dec 31, 2019 | 2.71 Mn |
API Access
Atara Biotherapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();